Souhaitez-vous accéder aux communiqués récents ?

At 6-month follow-up, a single 240 mg dose of WVE-007 (INHBE GalNAc-siRNA) continued to drive significant placebo-adjusted reductions in visceral fat (-14%; p<0.05) and total fat (-5%),...

Intranasal oxytocin blocks the release of calcitonin gene-related peptide (CGRP) in animal models and is the core technology of TNX-1900 for craniofacial pain conditions, including migraine and...

Lifecore Biomedical Signs Two New Agreements with Existing U.S. Biopharmaceutical Customer

San Antonio Center Cleared to Commence Commercial Sales of Normal Source PlasmaState of the Art Facility has Annual Collection Capacity of Approximately 50,000 Liters of Plasma and an Estimated Annual...

MONTRÉAL, 26 mars 2026 (GLOBE NEWSWIRE) -- Alors que les campagnes de prévention sur l’alcool et le cannabis ciblent principalement les jeunes, les réalités des personnes de 50 ans et plus...

Hyderabad, March 26, 2026 (GLOBE NEWSWIRE) -- According to Mordor Intelligence, the home healthcare market size was valued at USD 335.22 billion in 2025 and is projected to grow from USD 363.58...

Washington, DC, March 25, 2026 (GLOBE NEWSWIRE) -- ATI Advisory analysis examines 2024 Medicare Shared Savings Program (MSSP) performance data to assess how episode-level spending, post-acute...

SAN JOSE, Calif., March 25, 2026 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

Trial demonstrated no safety concerns when co-administering roluperidone and olanzapine The Company continues to advance the program, with the confirmatory Phase 3 trial now enrolling and topline...

Evaluating Potential to Preserve Muscle Mass Associated with Weight Reduction Announces Preclinical Study Initiation, Patent Filing and Publication of Independent Scientific Research SOLANA BEACH,...